Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
PreciThera, Inc. logo — company profile

PreciThera, Inc.

Founded 2016 Canada Montreal, Canada 3 employees Series A Total: $36.00M Biotechnology, Health and Wellness +1

General Information

Company Name PreciThera, Inc.
Founded Year 2016
Location Canada Montreal, Canada
Employees 3
Industries Biotechnology, Health and Wellness, Pharmaceutical
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with PreciThera, Inc.. To contact PreciThera, Inc., visit precithera.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does PreciThera, Inc. compare?

A PDF of PreciThera, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting PreciThera, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About PreciThera, Inc.

PreciThera, Inc. is a biotechnology company founded in 2016 with a mission to develop therapies for rare bone diseases. The company utilizes computational technology and a deep understanding of disease pathology to target heterogeneous genetic disorders primarily affecting bone function. Their approach aims to address skeletal symptoms and extraskeletal issues in patients. In July 2017, PreciThera secured a significant $36.00M Series A investment from notable investors including Arix Bioscience, CTI Life Sciences Fund, Sanderling Ventures, Emerillon Capital, and Fonds de solidarité FTQ. With its focus on addressing unmet medical needs in the biotechnology and pharmaceutical industries, PreciThera presents a promising investment opportunity in the field of rare disease therapeutics.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $36.00M 5
Arix Bioscience CTI Life Sciences Fund Sanderling Ventures
Arix Bioscience, CTI Life Sciences Fund +3
27 Jul 2017

PreciThera, Inc. Alternatives & Competitors

View All Alternatives
PreciThera, Inc. vs
Innoskel
Innoskel France

Developing novel therapies for rare bone diseases

Series A
2 employees
Biotechnology, Health and Wellness
PreciThera, Inc. vs
Pretzel Therapeutics
Pretzel Therapeutics United States

Welcome to a new era in mitochondrial therapeutics

Series A
46 employees
Biotechnology, Health and Wellness
PreciThera, Inc. vs
ReviR Therapeutics
ReviR Therapeutics United States

Improve human health by Revising drug discovery using RNA and AI technologies

Series A
22 employees
Biotechnology, Health and Wellness
View all alternatives

FAQ About PreciThera, Inc.

PreciThera, Inc. is a biotechnology company committed to the development of therapies for rare bone diseases using the combined application of computational technology and a deep understanding of disease pathology. The company focuses on heterogeneous genetic disorders that primarily manifest in bon...
PreciThera, Inc. was founded in 2016.
PreciThera, Inc. is headquartered in Montreal, Canada.
PreciThera, Inc. operates in Biotechnology, Health and Wellness and Pharmaceutical.
PreciThera, Inc. has approximately 3 employees.
PreciThera, Inc. has completed 1 funding round, raising a total of $36.00M. The latest funding stage is Series A.
Top alternatives and competitors to PreciThera, Inc. include Innoskel, Pretzel Therapeutics, ReviR Therapeutics, Alector, Santaris Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PreciThera, Inc. and Innoskel are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for PreciThera, Inc., https://bouncewatch.com/company/precithera-inc, updated 26 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes